Business Context and Reporting Period
This Form 8-K filing by Amedica Corporation (noted as Sintx Technologies in metadata) covers the period ending August 20, 2015. The company is an innovative biomaterial firm developing and manufacturing silicon nitride for biomedical applications, including spinal fusion products and implant components for hip and knee arthroplasty. The report addresses a regulatory matter regarding the company's continued listing on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance status regarding stock price requirements rather than financial performance metrics.
Material Changes and Regulatory Status
- Initial Non-Compliance: On February 19, 2015, Nasdaq notified the company that its common stock bid price had closed below the $1.00 minimum requirement for 30 consecutive trading days.
- Extension Granted: On August 19, 2015, Nasdaq granted an additional 180-day grace period, extending the deadline to February 15, 2016, to regain compliance.
- Compliance Criteria: To maintain listing, the company must maintain a minimum closing bid price of at least $1.00 for 10 consecutive trading days during the new grace period.
- Remediation Plan: The company has notified Nasdaq of its intention to cure the deficiency by effecting a reverse stock split if necessary.
Outlook, Risks, and Management Commentary
Management states that the Nasdaq letter does not impact the company's current listing status, and stock will continue to trade under the symbol "AMDA." However, if the company fails to regain compliance by February 15, 2016, Nasdaq will issue a delisting notification. The company may appeal such a determination to a NASDAQ Hearings Panel, though there is no assurance of success. The filing includes standard forward-looking statements warning that actual results may differ due to uncertainties, including the risk of failing to maintain a Nasdaq listing.
Investor Verification Checklist
- Verify the current trading price of Amedica Corporation (AMDA) to assess proximity to the $1.00 threshold.
- Confirm whether the company has filed a proposal for a reverse stock split with Nasdaq or its shareholders.
- Review the company's most recent Form 10-K (filed March 24, 2015) for detailed risk factors and financial health.
- Monitor future 8-K filings for updates on the compliance status before the February 15, 2016 deadline.